These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25243421)

  • 1. Low-dose cyclophosphamide improves survival in a murine treatment model of sepsis.
    Brown I; Bellevue O; Shawo A; Woldesemayat H; Lyo V; Rayikanti B; Lee M; Uzosike ED; Kasravi S; Harris HW
    Shock; 2015 Jan; 43(1):92-8. PubMed ID: 25243421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem and normal saline with cyclophosphamide have positive effects on the intestinal barrier in rats with sepsis.
    Yang J; Zhang S; Wu J; Zhang J; Dong J; Guo P; Tang S; Zhang W; Wu F
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Jun; 162(2):90-98. PubMed ID: 29935492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of bacterial translocation from the gastrointestinal tract of mice injected with cyclophosphamide.
    Suzuki T; Itoh K; Hagiwara T; Nakayama H; Honjyo K; Hirota Y; Kaneko T; Suzuki H
    Curr Microbiol; 1996 Aug; 33(2):78-83. PubMed ID: 8662176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice.
    Belikoff BG; Hatfield S; Georgiev P; Ohta A; Lukashev D; Buras JA; Remick DG; Sitkovsky M
    J Immunol; 2011 Feb; 186(4):2444-53. PubMed ID: 21242513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of imipenem and TAK-242, a Toll-like receptor 4 signal transduction inhibitor, improves survival in a murine model of polymicrobial sepsis.
    Sha T; Iizawa Y; Ii M
    Shock; 2011 Feb; 35(2):205-9. PubMed ID: 20720515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose cisplatin administration to septic mice improves bacterial clearance and programs peritoneal macrophage polarization to M1 phenotype.
    Li Y; Wang Z; Ma X; Shao B; Gao X; Zhang B; Xu G; Wei Y
    Pathog Dis; 2014 Nov; 72(2):111-23. PubMed ID: 24850793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local cell-associated immunity in the Peyer's patches of mouse intestines.
    Marneerushapisal V; Rowley D
    Infect Immun; 1981 Aug; 33(2):338-42. PubMed ID: 7275306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liu-Shen-Wan, a traditional Chinese medicine, improves survival in sepsis induced by cecal ligation and puncture via reducing TNF-alpha levels, MDA content and enhancing macrophage phagocytosis.
    Ma H; Kou J; Zhu D; Yan Y; Yu B
    Int Immunopharmacol; 2006 Aug; 6(8):1355-62. PubMed ID: 16782549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C-delta inhibition is organ-protective, enhances pathogen clearance, and improves survival in sepsis.
    Liverani E; Tursi SA; Cornwell WD; Mondrinos MJ; Sun S; Buttaro BA; Wolfson MR; Rogers TJ; Tükel Ç; Kilpatrick LE
    FASEB J; 2020 Feb; 34(2):2497-2510. PubMed ID: 31908004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory dose of clindamycin in combination with ceftriaxone improves survival and prevents organ damage in murine polymicrobial sepsis.
    Patel AM; Periasamy H; Mokale SN
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1671-1679. PubMed ID: 32383029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanshinone IIA attenuates sepsis-induced immunosuppression and improves survival rate in a mice peritonitis model.
    Gao M; Ou H; Jiang Y; Wang K; Peng Y; Zhang H; Yang M; Xiao X
    Biomed Pharmacother; 2019 Apr; 112():108609. PubMed ID: 30784917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient receptor potential melastatin 2 protects mice against polymicrobial sepsis by enhancing bacterial clearance.
    Qian X; Numata T; Zhang K; Li C; Hou J; Mori Y; Fang X
    Anesthesiology; 2014 Aug; 121(2):336-51. PubMed ID: 24781495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-34 Ameliorates Survival and Bacterial Clearance in Polymicrobial Sepsis.
    Lin X; Luo H; Yan X; Song Z; Gao X; Xia Y; Zhang L; Yin Y; Cao J
    Crit Care Med; 2018 Jun; 46(6):e584-e590. PubMed ID: 29384785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of burn with and without Escherichia coli infection in rats on intestinal vs. splenic T-cell responses.
    Ravindranath T; Al-Ghoul W; Namak S; Fazal N; Durazo-Arvizu R; Choudhry M; Sayeed MM
    Crit Care Med; 2001 Dec; 29(12):2245-50. PubMed ID: 11801815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral vs. parenteral cyclophosphamide on in vitro IgA and IgG production by murine Peyer's patches and cultured jejunal fragments.
    Karacic JJ; Cowdery JS
    Immunopharmacol Immunotoxicol; 1987; 9(4):441-65. PubMed ID: 3501798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cyclophosphamide on the Peyer's patches in MRL1/1 and NZB/WF1 mice.
    Yoshioka H; Sugiyama T; Kita T
    J Exp Pathol; 1990; 5(1):19-27. PubMed ID: 2398422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of probiotics on intestinal barrier function in malnourished rats after liver transplantation.
    Ren ZG; Liu H; Jiang JW; Jiang L; Chen H; Xie HY; Zhou L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2011 Oct; 10(5):489-96. PubMed ID: 21947722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of macrophage colony-stimulating factor in polymicrobial sepsis according to studies using osteopetrotic (op/op) mice.
    Ogiku M; Kono H; Ishii K; Hosomura N; Fujii H
    J Surg Res; 2011 Jul; 169(1):106-16. PubMed ID: 20189586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effect of Melatonin Against Polymicrobial Sepsis Is Mediated by the Anti-bacterial Effect of Neutrophils.
    Xu L; Zhang W; Kwak M; Zhang L; Lee PCW; Jin JO
    Front Immunol; 2019; 10():1371. PubMed ID: 31275316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.
    Yamamoto M; Rennert P; McGhee JR; Kweon MN; Yamamoto S; Dohi T; Otake S; Bluethmann H; Fujihashi K; Kiyono H
    J Immunol; 2000 May; 164(10):5184-91. PubMed ID: 10799877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.